Sat.May 20, 2023 - Fri.May 26, 2023

article thumbnail

Setting the record straight on accelerated approval

PhRMA

As we’ve discussed on this blog before, the U.S. Food and Drug Administration’s (FDA) accelerated approval program has served as a critical lifeline for patients with serious and life-threatening conditions. The program was originally established at the urging of patient advocates during the height of the HIV/AIDS epidemic, in which patients waited years for the FDA to review and approve new treatments.

FDA 264
article thumbnail

Pharmacists are Overworked, Frustrated, and Unintentionally Absent from Patient Care: It’s Time to Rightsize the Role

Pharmacy Times

Specialty pharmacists—those caring for patients with serious, sometimes life-threatening conditions such as cancer or rheumatologic disease—are not immune from the ongoing labor crisis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Physicians, Staff Express Negative Attitudes Toward Emergency Department-Initiated Buprenorphine Use

Pharmacy Times

The attitudes of community-based opioid use disorder treatment center staff toward the emergency department as a site of initiation were varied, with some feeling that emergency department-initiated buprenorphine may attract patients who were not experiencing life-threatening emergencies.

131
131
article thumbnail

A National Drug Shortage Creates Care Challenges in Oncology

Drug Topics

A short supply of cisplatin and carboplatin is forcing health care providers to find less effective alternative treatments.

469
469
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Amid surging Duchenne market, Capricor touts potential ‘backbone’ therapy of the space

PharmaVoice

The company's CEO on the vital role its late-stage candidate could play in the lives of DMD patients.

264
264
article thumbnail

An Interview with Jamila Jorden, Pharmacy Advisor

Pharmacy Is Right For Me

Jamila Jorden, a pharmacist and academic advisor, recently gave an interview discussing the multifaceted role of pharmacists. She also discussed the importance of experiential education in preparing pharmacy students for their careers. Jamila’s experiences in the pharmacy profession provide valuable insight into the varied roles and responsibilities of pharmacists.

Hospitals 246

More Trending

article thumbnail

Fourth Dose of COVID Vaccine Produced Milder Symptoms In Patients With IBD

Drug Topics

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Vaccines 468
article thumbnail

Strangers in a strange land: 8 unlikely companies making plays in pharma

PharmaVoice

How these consumer and service companies are tapping into major trends in the biopharma industry.

264
264
article thumbnail

Probiotic Use Has Increased in Neonatal ICUs, But Further Data Are Still Needed

Pharmacy Times

In neonatal intensive care units, probiotic usage was associated with a decline in necrotizing enterocolitis, but not with sepsis or mortality rates.

144
144
article thumbnail

Employers face soaring demand for obesity care benefits. Virtual care players are jumping in with a slew of offerings

Fierce Healthcare

Employers face soaring demand for obesity care benefits.

141
141
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Two Lawsuits Allege Iowa Medicaid Did Not Provide Proper Mental Health Care

Drug Topics

Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.

Insurance 468
article thumbnail

The ‘superpowers’ pharma leaders should cultivate

PharmaVoice

Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.

246
246
article thumbnail

Opinion: Cancer patients shouldn’t be responsible for out-of-pocket costs

STAT

In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure multiple CT and MRI studies and intensive medical care, including surgery, radiation, chemotherapy, or immunotherapy. Fortunately, advances in treatment and novel therapies have steadily improved survival following a cancer diagnosis. Cancer death rates have declined by 27% over the past 20 years.

article thumbnail

Five Trends Transforming Pharmacies into Wellness Centers of the Future

Pharmacy Times

With so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.

139
139
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Sulbactam-Durlobactam for Bacterial Pneumonia Gets FDA Approval

Drug Topics

The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.

Hospitals 468
article thumbnail

From FTC to SCOTUS, Amgen’s woes are potential ‘game changers’ for the industry

PharmaVoice

The two institutional battles offer a glimpse into the tension between pharma innovation and regulation that could reverberate across the industry.

246
246
article thumbnail

Johnson & Johnson cites rebates and discounts for drug price increases

Fierce Pharma

Johnson & Johnson cites rebates and discounts for drug price increases kdunleavy Fri, 05/26/2023 - 07:36

134
134
article thumbnail

Safety, Savings Start With Medication History

Pharmacy Times

Technicians should take advantage of opportunities to work at a higher level of practice, build their careers.

132
132
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Exploring the Link Between Low Socioeconomic Status and Risk of Invasive Pneumococcal Disease

Drug Topics

Active tobacco use and BMI were inversely related to the risk of developing IPD.

465
465
article thumbnail

The power of genetics — how research into gene sequencing could revolutionize biopharma

PharmaVoice

Ancient DNA from a deer tooth. A new way to connect genes with disease. Biological super-computing. These genetic advances could play a part in our biopharma future.

246
246
article thumbnail

Startup Florence acquires Zipnosis from Bright Health to build out telehealth services

Fierce Healthcare

Startup Florence acquires Zipnosis from Bright Health to build out telehealth services hlandi Wed, 05/24/2023 - 06:15

132
132
article thumbnail

Study Shows Link Between Nurses’ Work Environment, Hospital-Onset C. Diff

Pharmacy Times

Supportive nurse managers and supervisors as well as nurses’ involvement in organizational governance may help lower hospital-onset Clostridioides difficile infection in acute care hospitals.

Hospitals 132
article thumbnail

What Is The Link Between Antidepressants and Hospital-Acquired Clostridium Difficile Infection?

Drug Topics

Researchers found an increased occurrence of CDI in individuals who were prescribed antidepressants.

Hospitals 464
article thumbnail

Biotechs blast experiments into space

PharmaVoice

Conducting life sciences research in space’s microgravity could have far-ranging implications for drug development on Earth.

147
147
article thumbnail

New calculator demonstrates how improved adherence to anti-diabetic medicines can benefit people in Medicaid

PhRMA

Diabetes is a scary diagnosis for anyone. When people with the disease struggle to manage their blood sugar levels, they can experience significant, life-threatening and costly complications such as heart attack, stroke, kidney failure, amputation and blindness. Fortunately, diabetes can be well-managed with comprehensive access to health care services, including medicines.

130
130
article thumbnail

Pharmacists Can Educate Patients, Provide Counseling for Smoking Cessation

Pharmacy Times

OTC nicotine replacement products can come in a transdermal patch, nicotine gum, or lozenges.

132
132
article thumbnail

FDA Approves First Oral Treatment for Patients With Moderate to Severe Crohn's Disease

Drug Topics

The approval of Rinvoq (upadacitinib) was based on the results of three clinical trials: two induction therapy studies and one maintenance study.

FDA 460
article thumbnail

3 FDA decisions that could be delayed if the U.S. defaults on its debt

PharmaVoice

If federal lawmakers don’t vote to raise the debt limit by early June, these FDA actions could be impacted.

FDA 130
article thumbnail

Biopharmaceutical manufacturing companies continue to expand their economic footprint across the United States

PhRMA

Before 2020, the importance of robust and resilient supply chains and how they can affect access to life-saving treatments probably wasn’t top of mind for many outside the biopharmaceutical industry. Then, in a sudden and very real way, the COVID-19 pandemic showed just how critical it is to have manufacturing facilities capable of scaling up quickly to meet an urgent public health demand.

Vaccines 130
article thumbnail

Epic is going all in on generative AI in healthcare. Here's why a handful of health systems are eager to test-drive it

Fierce Healthcare

Epic is going all in on generative AI in healthcare.

129
129
article thumbnail

First Oral Antiviral Treatment For COVID-19 Gets FDA Approval

Drug Topics

More than 11.6 million treatment courses of the medication have been prescribed in the U.S. to date.

FDA 452
article thumbnail

Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi

PharmaVoice

As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.

130
130
article thumbnail

FDA Approves Avapritinib for the Treatment of Indolent Systemic Mastocytosis

Pharmacy Times

Avapritinib has been FDA approved for the treatment of advanced systemic mastocytosis since June 2021.

FDA 129